Extended Duration Bridge to Orthotopic Heart Transplant Utilizing the Impella RP Flex
- PMID: 39620305
- DOI: 10.1097/MAT.0000000000002221
Extended Duration Bridge to Orthotopic Heart Transplant Utilizing the Impella RP Flex
Abstract
We present a case of a 56 year old man presenting with cardiogenic shock from isolated right ventricular failure due to arrhythmogenic right ventricular cardiomyopathy who was successfully bridged to heart transplantation after 29 days on an Impella RP Flex right ventricular assist device. This represents the longest reported duration of support with the device to date and highlights the utility of this platform in the management of severe right ventricular failure.
Copyright © ASAIO 2024.
Conflict of interest statement
Disclosure: The authors have no conflicts of interest to report.
References
-
- Josiassen J, Helgestad OKL, Møller JE, et al.: Cardiogenic shock due to predominantly right ventricular failure complicating acute myocardial infarction. Eur Heart J Acute Cardiovasc Care. 10: 33–39, 2021.
-
- Goldstein JA, Hanson I: Impella RP for treatment of right ventricular shock: Appropriate unloading never gets old. Catheter Cardiovasc Interv. 96: 382–383, 2020.
-
- Han JJ: Impella RP Flex with SmartAssist receives FDA pre-market approval. Artif Organs. 47: 10–11, 2023.
-
- Anderson MB, Goldstein J, Milano C, et al.: Benefits of a novel percutaneous ventricular assist device for right heart failure: The prospective RECOVER RIGHT study of the Impella RP device. J Heart Lung Transplant. 34: 1549–1560, 2015.
-
- Botti G, Gramegna M, Burzotta F, et al.; IMP IT Investigators: Impella RP for patients with acute right ventricular failure and cardiogenic shock: A subanalysis from the IMP-IT Registry. J Pers Med. 12: 1481, 2022.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
